• Kirk Hartley

Myriad’s BRCA Gene Patent Wars Continue – A New Entrant Joins the Fray

The Myriad BRCA gene patent wars are continuing, and a new entrant has started a new fray by suing Myriad in a declaratory judgment suit. The Genomics Law Report provides a cogent summary.

#PatentClaimsTrolls

0 views0 comments

Recent Posts

See All

Patent litigation is dropping, but remains a significant sector in the litigation industry. Links to patent litigation statistics are part of an October 29, 2014 post on patent litigation at Marginal